Your browser doesn't support javascript.
A national survey of COVID-19 vaccine acceptance in Nigeria.
Al-Mustapha, Ahmad Ibrahim; Okechukwu, Ochulor; Olayinka, Ademola; Muhammed, Oyeniyi Rasheed; Oyewo, Muftau; Owoicho, Samuel A; Abubakar, Ahmed Tijani; Olabisi, Abdulsalam; Jibril, Aliyu; Ereh, Simon; Fakayode, Oluwatosin Enoch; Ogundijo, Oluwaseun Adeolu; Elelu, Nusirat; Adetunji, Victoria Olusola.
  • Al-Mustapha AI; Department of Veterinary Services, Kwara State Ministry of Agriculture and Rural Development, Ilorin, Kwara State, Nigeria; Department of Veterinary Public Health and Preventive Medicine, Faculty of Veterinary Medicine, University of Ibadan, Oyo State, Nigeria; Infectious Diseases and One Health, Fa
  • Okechukwu O; Institute of Virology, Hannover Biomedical Research School, 30625 Hannover, Germany.
  • Olayinka A; Department of Medical Microbiology and Parasitology, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun state, Nigeria.
  • Muhammed OR; Department of Public Health, Kwara State Ministry of Health, Ilorin, Kwara State, Nigeria.
  • Oyewo M; Department of Veterinary Services, Kwara State Ministry of Agriculture and Rural Development, Ilorin, Kwara State, Nigeria; Nigerian Filed Epidemiology and Laboratory Training program, Asokoro, Abuja, Nigeria.
  • Owoicho SA; Nigerian Filed Epidemiology and Laboratory Training program, Asokoro, Abuja, Nigeria; Federal Ministry of Agriculture and rural Development, Benin City, Edo State, Nigeria.
  • Abubakar AT; Department of Veterinary Services, Kwara State Ministry of Agriculture and Rural Development, Ilorin, Kwara State, Nigeria; African Center for Disease Control and Prevention, Abuja, Nigeria.
  • Olabisi A; Department of Public Health, Kwara State Ministry of Health, Ilorin, Kwara State, Nigeria.
  • Jibril A; Faculty of Veterinary Medicine, Usmanu Danfodiyo University, Sokoto, Nigeria.
  • Ereh S; Department of Internal Medicine, University of Calabar Teaching Hospital, Calabar, Cross River State, Nigeria.
  • Fakayode OE; Department of Public Health, Kwara State Ministry of Health, Ilorin, Kwara State, Nigeria.
  • Ogundijo OA; Department of Veterinary Public Health and Preventive Medicine, Faculty of Veterinary Medicine, University of Ibadan, Oyo State, Nigeria.
  • Elelu N; Department of Veterinary Public Health and Preventive Medicine, Faculty of Veterinary Medicine, University of Ilorin, Kwara State, Nigeria.
  • Adetunji VO; Department of Veterinary Public Health and Preventive Medicine, Faculty of Veterinary Medicine, University of Ibadan, Oyo State, Nigeria.
Vaccine ; 40(33): 4726-4731, 2022 08 05.
Article in English | MEDLINE | ID: covidwho-1907850
ABSTRACT

INTRODUCTION:

The COVID-19 vaccine is essential to reduce the global impact of the pandemic. Understanding its acceptance is key to Nigeria's national COVID-19 control strategies.

METHODS:

Between the 6th and 22nd of January 2021, we conducted a non-probability convenience sampling of 3076 respondents using online and in-person interviews to assess the prevalence and predictors of the COVID-19 vaccine acceptance in Nigeria.

FINDINGS:

Of the 3076 recruited participants, 74.7% (n = 2300/3076) had tertiary education. The median age group was 30-39 years (35.1%, n = 1097/3076) whereas 31% (n = 952/3076) of all respondents had a monthly income<30,000 Naira (65 USD). The survey results indicated that a wide range of the respondents were in government employment (34.1%, n = 1050/3076). The majority of our study participants (92.2%, n = 2835/3076) believe that COVID-19 is real and not a hoax. Only 27.9% (n = 858/3076) of the study participants have been tested for COVID-19 and 17.8 % (n = 152/858) of the tested respondents were COVID-19 positive by PCR. Half (50.7%; n = 1560/3076) of the study participants were willing to take the vaccine once available. The majority of the respondents (81.1%, n = 2496/3076) were not willing to pay for the vaccine. Only 15.9% (n = 483/3076) of the respondents rated the government's handling of the pandemic above average. The potential acceptance of the COVID-19 vaccine was significantly affected by the age and the monthly income of the respondents. Respondents older than 60 years old (OR 3.02, 95% CI 1.69,5.41; p < 0.001) and those that earn between 250,000-500,000 Naira monthly (OR 1.38; 95% CI 1.11,1.70; p < 0.001) were more likely to accept the COVID-19 vaccine respectively. In addition, the respondents' perception of the existence of the disease (OR 1.45; 95% CI 0.99,2.18; p > 0.05), the need for a COVID-19 vaccine (OR 16; 95% CI 11.63,22.10; p < 0.001), the willingness to pay (OR 1.68; 95% CI 1.39,2.01; p < 0.001) and the rating of the government handling of the pandemic (OR 2.25; 95% CI 1.57,3.23; p < 0.001) were critical to the acceptance of the COVID-19 vaccine.

INTERPRETATION:

With 50.7% vaccine acceptance, Nigeria's public health policymakers must prioritize and develop strategies that will effectively increase COVID-19 vaccine acceptance across the country with emphasis on trust, transparency and strong leadership.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Humans / Middle aged Country/Region as subject: Africa Language: English Journal: Vaccine Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Humans / Middle aged Country/Region as subject: Africa Language: English Journal: Vaccine Year: 2022 Document Type: Article